|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.860 INR | +0.91% |
|
-2.32% | -38.04% |
| Market Cap | 1.73B 18.15M 15.77M 14.68M 13.48M 25.46M 25.85M 173M 67.92M 862M 68.15M 66.65M 2.89B | P/E 2024 |
26x | P/E 2025 | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 15.27M 13.27M 12.35M 11.34M 21.42M 21.75M 146M 57.15M 726M 57.34M 56.08M 2.43B | EV / Sales 2024 |
3.67x | EV / Sales 2025 | 1.79x |
| Free-Float |
65.03% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.91% | ||
| 1 week | -2.32% | ||
| Current month | -17.35% | ||
| 1 month | -17.35% | ||
| 3 months | -11.31% | ||
| 6 months | -27.97% | ||
| Current year | -38.04% |
| 1 week | 8.25 | 9.25 | |
| 1 month | 8.25 | 10.85 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 17.25 | |
| 3 years | 6.86 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | - | 20/12/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.91% | -2.32% | -31.32% | +32.24% | 22.34M | ||
| -0.53% | -3.95% | +55.23% | +152.74% | 1,030B | ||
| +0.21% | -2.68% | +55.61% | +53.02% | 617B | ||
| -2.51% | -3.25% | +32.76% | +67.76% | 455B | ||
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | ||
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | ||
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | ||
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | ||
| -0.64% | +2.43% | +30.52% | +64.49% | 209B | ||
| -0.82% | +0.70% | +15.96% | +71.01% | 163B | ||
| Average | -0.90% | +4.15% | +23.24% | +48.50% | 361.27B | |
| Weighted average by Cap. | -0.76% | +4.87% | +38.47% | +72.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 867M 9.08M 7.9M 7.35M 6.75M 12.74M 12.94M 86.64M 34M 432M 34.12M 33.37M 1.45B | 1.38B 14.45M 12.56M 11.69M 10.73M 20.27M 20.58M 138M 54.07M 687M 54.25M 53.06M 2.3B |
| Net income | 132M 1.38M 1.2M 1.12M 1.03M 1.94M 1.97M 13.16M 5.17M 65.59M 5.18M 5.07M 220M | 181M 1.9M 1.65M 1.54M 1.41M 2.66M 2.7M 18.11M 7.11M 90.22M 7.13M 6.97M 303M |
| Net Debt | -413M -4.33M -3.76M -3.5M -3.21M -6.07M -6.16M -41.26M -16.19M -206M -16.25M -15.89M -689M | -275M -2.88M -2.5M -2.33M -2.14M -4.04M -4.1M -27.45M -10.77M -137M -10.81M -10.57M -459M |
Employees
115
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹8.860 | +0.91% | 341,834 |
| 30/07/26 | ₹8.780 | -1.01% | 194,739 |
| 29/07/26 | ₹8.870 | -1.33% | 337,907 |
| 28/07/26 | ₹8.990 | +0.78% | 167,369 |
| 27/07/26 | ₹8.920 | -1.76% | 692,535 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















